carbostyril has been researched along with Meningitis, Pneumococcal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Flatz, L; Kühn, F; Müller, HP; Pfister, M; Stucki, A | 1 |
| Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
| Brück, W; Chen, V; Dalhoff, A; Kohlsdorfer, C; Nau, R; Schmidt, H; Schneider, O; Stuertz, K; Trostdorf, F | 1 |
| Frimodt-Møller, N; Knudsen, JD; Ostergaard, C; Sørensen, TK | 1 |
| Ghaffar, F; Hardy, RD; Iglehart, J; McCracken, GH; Michelow, IC; Olsen, K; Rodriguez-Cerrato, V; Saavedra, J | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG | 1 |
| Furubou, S; Minami, S; Morita, T; Narita, H; Takahata, M; Todo, Y; Watanabe, Y; Yamada, H | 1 |
7 other study(ies) available for carbostyril and Meningitis, Pneumococcal
| Article | Year |
|---|---|
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Kinetics; Meninges; Meningitis, Pneumococcal; Mutation; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin | 2004 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Moxifloxacin in the therapy of experimental pneumococcal meningitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Fluoroquinolones; Meningitis, Pneumococcal; Moxifloxacin; Pneumococcal Infections; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae | 1998 |
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Drug Evaluation; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Protein Binding; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin | 1998 |
BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporin Resistance; Fluoroquinolones; Indoles; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Vancomycin | 2001 |
Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Disease Models, Animal; Fluoroquinolones; Indoles; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Treatment Outcome | 2002 |
Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.
Topics: Animals; Anti-Infective Agents; Brain; Ceftriaxone; Cephalosporins; Fluoroquinolones; Indoles; Injections, Intravenous; Isoindoles; Male; Meningitis, Pneumococcal; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae | 2002 |